Nonocclusive Mesenteric Ischemia after Chemotherapy in an Adolescent Patient with a History of Three Allogeneic Hematopoietic Stem Cell Transplantations for Acute Lymphoblastic Leukemia

Nonocclusive mesenteric ischemia (NOMI) is induced by intestinal vasospasm without thromboembolic occlusion and is associated with high morbidity and mortality. The estimated overall incidence of autopsy-verified fatal NOMI is 2.0 cases/100,000 person-years; however, no pediatric or adolescent cases...

Full description

Bibliographic Details
Main Authors: Koichi Hirabayashi, Mitsuho Takatsuki, Mitsuo Motobayashi, Takashi Kurata, Shoji Saito, Tomonari Shigemura, Yozo Nakazawa, Kazuo Sakashita, Satoshi Ishizone, Hiroyoshi Ota, Kenichi Koike
Format: Article
Language:English
Published: Elsevier 2017-02-01
Series:Pediatrics and Neonatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S187595721400165X
_version_ 1818999134790615040
author Koichi Hirabayashi
Mitsuho Takatsuki
Mitsuo Motobayashi
Takashi Kurata
Shoji Saito
Tomonari Shigemura
Yozo Nakazawa
Kazuo Sakashita
Satoshi Ishizone
Hiroyoshi Ota
Kenichi Koike
author_facet Koichi Hirabayashi
Mitsuho Takatsuki
Mitsuo Motobayashi
Takashi Kurata
Shoji Saito
Tomonari Shigemura
Yozo Nakazawa
Kazuo Sakashita
Satoshi Ishizone
Hiroyoshi Ota
Kenichi Koike
author_sort Koichi Hirabayashi
collection DOAJ
description Nonocclusive mesenteric ischemia (NOMI) is induced by intestinal vasospasm without thromboembolic occlusion and is associated with high morbidity and mortality. The estimated overall incidence of autopsy-verified fatal NOMI is 2.0 cases/100,000 person-years; however, no pediatric or adolescent cases have yet been reported. An 18-year-old female was diagnosed with B-cell precursor acute lymphoblastic leukemia at the age of 10 years. Our patient received three allogeneic hematopoietic stem cell transplantations but experienced hematological relapse after each. She received combination therapy of prednisolone, L-asparaginase, vincristine, and bortezomib after the third relapse. On Day 16 after the initiation of chemotherapy, she developed NOMI; therefore, we performed a right-sided hemicolectomy on Day 27. Nonocclusive mesenteric ischemia should be considered during the differential diagnosis of intestinal complications after chemotherapy, even in pediatric and adolescent patients.
first_indexed 2024-12-20T22:12:36Z
format Article
id doaj.art-b8dbae6b881b40a49834d2d9b61a3051
institution Directory Open Access Journal
issn 1875-9572
language English
last_indexed 2024-12-20T22:12:36Z
publishDate 2017-02-01
publisher Elsevier
record_format Article
series Pediatrics and Neonatology
spelling doaj.art-b8dbae6b881b40a49834d2d9b61a30512022-12-21T19:25:08ZengElsevierPediatrics and Neonatology1875-95722017-02-01581818410.1016/j.pedneo.2014.07.008Nonocclusive Mesenteric Ischemia after Chemotherapy in an Adolescent Patient with a History of Three Allogeneic Hematopoietic Stem Cell Transplantations for Acute Lymphoblastic LeukemiaKoichi Hirabayashi0Mitsuho Takatsuki1Mitsuo Motobayashi2Takashi Kurata3Shoji Saito4Tomonari Shigemura5Yozo Nakazawa6Kazuo Sakashita7Satoshi Ishizone8Hiroyoshi Ota9Kenichi Koike10Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, JapanDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, JapanDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, JapanDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, JapanDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, JapanDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, JapanDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, JapanDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, JapanFirst Department of Surgery, Shinshu University School of Medicine, Matsumoto, JapanDepartment of Biomedical Sciences, School of Health Sciences, Shinshu University School of Medicine, Matsumoto, JapanDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, JapanNonocclusive mesenteric ischemia (NOMI) is induced by intestinal vasospasm without thromboembolic occlusion and is associated with high morbidity and mortality. The estimated overall incidence of autopsy-verified fatal NOMI is 2.0 cases/100,000 person-years; however, no pediatric or adolescent cases have yet been reported. An 18-year-old female was diagnosed with B-cell precursor acute lymphoblastic leukemia at the age of 10 years. Our patient received three allogeneic hematopoietic stem cell transplantations but experienced hematological relapse after each. She received combination therapy of prednisolone, L-asparaginase, vincristine, and bortezomib after the third relapse. On Day 16 after the initiation of chemotherapy, she developed NOMI; therefore, we performed a right-sided hemicolectomy on Day 27. Nonocclusive mesenteric ischemia should be considered during the differential diagnosis of intestinal complications after chemotherapy, even in pediatric and adolescent patients.http://www.sciencedirect.com/science/article/pii/S187595721400165Xacute lymphoblastic leukemiaadolescentallogeneic hematopoietic stem cell transplantationchemotherapynonocclusive mesenteric ischemia
spellingShingle Koichi Hirabayashi
Mitsuho Takatsuki
Mitsuo Motobayashi
Takashi Kurata
Shoji Saito
Tomonari Shigemura
Yozo Nakazawa
Kazuo Sakashita
Satoshi Ishizone
Hiroyoshi Ota
Kenichi Koike
Nonocclusive Mesenteric Ischemia after Chemotherapy in an Adolescent Patient with a History of Three Allogeneic Hematopoietic Stem Cell Transplantations for Acute Lymphoblastic Leukemia
Pediatrics and Neonatology
acute lymphoblastic leukemia
adolescent
allogeneic hematopoietic stem cell transplantation
chemotherapy
nonocclusive mesenteric ischemia
title Nonocclusive Mesenteric Ischemia after Chemotherapy in an Adolescent Patient with a History of Three Allogeneic Hematopoietic Stem Cell Transplantations for Acute Lymphoblastic Leukemia
title_full Nonocclusive Mesenteric Ischemia after Chemotherapy in an Adolescent Patient with a History of Three Allogeneic Hematopoietic Stem Cell Transplantations for Acute Lymphoblastic Leukemia
title_fullStr Nonocclusive Mesenteric Ischemia after Chemotherapy in an Adolescent Patient with a History of Three Allogeneic Hematopoietic Stem Cell Transplantations for Acute Lymphoblastic Leukemia
title_full_unstemmed Nonocclusive Mesenteric Ischemia after Chemotherapy in an Adolescent Patient with a History of Three Allogeneic Hematopoietic Stem Cell Transplantations for Acute Lymphoblastic Leukemia
title_short Nonocclusive Mesenteric Ischemia after Chemotherapy in an Adolescent Patient with a History of Three Allogeneic Hematopoietic Stem Cell Transplantations for Acute Lymphoblastic Leukemia
title_sort nonocclusive mesenteric ischemia after chemotherapy in an adolescent patient with a history of three allogeneic hematopoietic stem cell transplantations for acute lymphoblastic leukemia
topic acute lymphoblastic leukemia
adolescent
allogeneic hematopoietic stem cell transplantation
chemotherapy
nonocclusive mesenteric ischemia
url http://www.sciencedirect.com/science/article/pii/S187595721400165X
work_keys_str_mv AT koichihirabayashi nonocclusivemesentericischemiaafterchemotherapyinanadolescentpatientwithahistoryofthreeallogeneichematopoieticstemcelltransplantationsforacutelymphoblasticleukemia
AT mitsuhotakatsuki nonocclusivemesentericischemiaafterchemotherapyinanadolescentpatientwithahistoryofthreeallogeneichematopoieticstemcelltransplantationsforacutelymphoblasticleukemia
AT mitsuomotobayashi nonocclusivemesentericischemiaafterchemotherapyinanadolescentpatientwithahistoryofthreeallogeneichematopoieticstemcelltransplantationsforacutelymphoblasticleukemia
AT takashikurata nonocclusivemesentericischemiaafterchemotherapyinanadolescentpatientwithahistoryofthreeallogeneichematopoieticstemcelltransplantationsforacutelymphoblasticleukemia
AT shojisaito nonocclusivemesentericischemiaafterchemotherapyinanadolescentpatientwithahistoryofthreeallogeneichematopoieticstemcelltransplantationsforacutelymphoblasticleukemia
AT tomonarishigemura nonocclusivemesentericischemiaafterchemotherapyinanadolescentpatientwithahistoryofthreeallogeneichematopoieticstemcelltransplantationsforacutelymphoblasticleukemia
AT yozonakazawa nonocclusivemesentericischemiaafterchemotherapyinanadolescentpatientwithahistoryofthreeallogeneichematopoieticstemcelltransplantationsforacutelymphoblasticleukemia
AT kazuosakashita nonocclusivemesentericischemiaafterchemotherapyinanadolescentpatientwithahistoryofthreeallogeneichematopoieticstemcelltransplantationsforacutelymphoblasticleukemia
AT satoshiishizone nonocclusivemesentericischemiaafterchemotherapyinanadolescentpatientwithahistoryofthreeallogeneichematopoieticstemcelltransplantationsforacutelymphoblasticleukemia
AT hiroyoshiota nonocclusivemesentericischemiaafterchemotherapyinanadolescentpatientwithahistoryofthreeallogeneichematopoieticstemcelltransplantationsforacutelymphoblasticleukemia
AT kenichikoike nonocclusivemesentericischemiaafterchemotherapyinanadolescentpatientwithahistoryofthreeallogeneichematopoieticstemcelltransplantationsforacutelymphoblasticleukemia